Syncell Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$97.4M
- Investors
-
17
Syncell General Information
Description
Developer of a spatial biology system designed to address unattainable complex biological problems. The company's system turns a high-content microscope into a precision photolabeling machine to revolutionize spatial biology and assist in high-content de novo spatial proteomics for the identification of novel proteins for basic research and novel biomarkers for diseases, enabling researchers to harvest all proteins in selected subcellular locations.
Contact Information
Website
www.syncell.comCorporate Office
- Number 99, Lane 130, Sec I, Academia Road
- Nangang District
- Taipei City, 115
- Taiwan
Corporate Office
- Number 99, Lane 130, Sec I, Academia Road
- Nangang District
- Taipei City, 115
- Taiwan
Syncell Timeline
Syncell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 11-Nov-2025 | $97.4M | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series A) | 11-Dec-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 27-May-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 13-Sep-2023 | $8M | $8M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 09-Jul-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Syncell Patents
Syncell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026145690-A1 | Self-calibration method and microscope-based system for illumination uniformity | Pending | 31-Dec-2024 | ||
| WO-2026119237-A1 | Method for calibration of a microscope-based system | Pending | 04-Dec-2024 | ||
| WO-2026119237-A9 | Method for calibration of a microscope-based system | Pending | 04-Dec-2024 | ||
| WO-2026098512-A1 | Method of illumination | Pending | 05-Nov-2024 | ||
| US-20260110877-A1 | Optical device and fixing apparatus for optical component | Pending | 22-Oct-2024 | G02B21/26 |
Syncell Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Everbright Biofund | Venture Capital | Minority | ||
| Abicor Binzel | Corporation | Minority | ||
| BE Health Ventures | Venture Capital | Minority | ||
| China Everbright | Asset Manager | Minority | ||
| Himalaya Capital | Venture Capital | Minority |
Syncell FAQs
-
When was Syncell founded?
Syncell was founded in 2020.
-
Where is Syncell headquartered?
Syncell is headquartered in Taipei City, Taiwan.
-
What industry is Syncell in?
Syncell’s primary industry is Discovery Tools (Healthcare).
-
Is Syncell a private or public company?
Syncell is a Private company.
-
What is Syncell’s current revenue?
The current revenue for Syncell is .
-
How much funding has Syncell raised over time?
Syncell has raised $127M.
-
Who are Syncell’s investors?
Everbright Biofund, Abicor Binzel, BE Health Ventures, China Everbright, and Himalaya Capital are 5 of 17 investors who have invested in Syncell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
